Xencor XNCR
NASDAQ XNCR
$26.62 +0.00 (+0.00%)
As of: Sep 4, 2026 · 1:41 PM EDT

Xencor (XNCR) Interest & Investment Income (2013 - 2026)

Xencor (XNCR) posted quarterly Interest & Investment Income of $5.5 million for Q1 2026, down 27.58% year-over-year from $7.5 million in Q1 2025, and down 11.95% quarter-over-quarter from $6.2 million in Q4 2025.

Analysis

Xencor (XNCR) Interest & Investment Income (2013 - 2026) Analysis & Trends

Xencor (XNCR) has reported Interest & Investment Income for 10 consecutive years, with $5.5 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Interest & Investment Income fell 27.58% year-over-year to $5.5 million; the TTM figure through Mar 2026 stood at $25.4 million (down 17.71% YoY), while the FY2025 annual figure was $27.5 million, down 13.8% from the prior year.
  • Interest & Investment Income slipped to $5.5 million in Q1 2026 per XNCR's latest filing, from $6.2 million in the prior quarter.
  • Across five years, Interest & Investment Income topped out at $8.5 million in Q1 2024 and bottomed at $2.9 million in Q1 2023.
  • Historically, Interest & Investment Income has averaged $6.8 million across 4 years, with a median of $7.4 million in 2024.
  • Annual changes were most pronounced in 2024 — Interest & Investment Income soared 194.86% — and 2026, when it retreated 27.58%.
  • Xencor's Interest & Investment Income stood at $2.9 million in 2023, then surged by 181.61% to $8.2 million in 2024, then fell by 24.06% to $6.2 million in 2025, then slipped by 11.95% to $5.5 million in 2026.
  • Business Quant data shows XNCR's Interest & Investment Income at $5.5 million in Q1 2026, $6.2 million in Q4 2025, and $6.5 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Vertex Pharmaceuticals 139.26 Bn 131.41 Bn 2.84 Bn 120.60 Mn
2 Regeneron Pharmaceuticals 85.64 Bn 77.64 Bn 3.93 Bn -48.00 Mn
3 Argenx Se 63.46 Bn 58.27 Bn 1.37 Bn 48.00 Mn
4 Moderna 57.83 Bn 52.69 Bn 52.00 Mn 67.00 Mn
5 Revolution Medicines 44.08 Bn 44.08 Bn - 35.58 Mn
6 BeOne Medicines 39.94 Bn 34.84 Bn 1.53 Bn 27.90 Mn
7 Alnylam Pharmaceuticals 35.19 Bn 31.88 Bn 992.69 Mn 28.14 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 5.13 Mn
9 Insmed 27.35 Bn 26.19 Bn 358.27 Mn 10.98 Mn
10 Xencor 2.02 Bn 1.64 Bn - 4.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.80 Mn
Mar 31, 2026 5.46 Mn
Dec 31, 2025 6.20 Mn
Sep 30, 2025 6.54 Mn
Jun 30, 2025 7.25 Mn
Mar 31, 2025 7.54 Mn
Dec 31, 2024 8.16 Mn
Sep 30, 2024 7.54 Mn
Jun 30, 2024 7.68 Mn
Mar 31, 2024 8.55 Mn
Mar 31, 2023 2.90 Mn
Jun 30, 2018 2.49 Mn
Mar 31, 2018 1.16 Mn
Dec 31, 2017 1.05 Mn
Sep 30, 2017 1.05 Mn
Jun 30, 2017 1.04 Mn
Mar 31, 2017 1.06 Mn
Dec 31, 2016 785,000.00
Sep 30, 2016 579,000.00
Jun 30, 2016 368,000.00